Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV461
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,407
Award facts
- Contract value 100% obligated
- $18,407.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,407.32 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors, with an ultimate completion date of January 13, 2026. This competitive award, issued on January 12, 2026, utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company Cencora, Inc. providing organizational oversight. The product will be delivered to the Conshohocken, PA location.
This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. Dupixent is a biologic treatment for eczema, asthma, and other inflammatory conditions commonly used in military healthcare systems. The award reflects AmerisourceBergen's established position as a critical pharmaceutical distributor for federal medical procurement, demonstrating its capability to efficiently fulfill government contracts for essential prescription medications and medical commodities required by military treatment facilities and other federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FV461?
SPE2DR26FV461 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV461 worth?
The government has obligated $18,407 on SPE2DR26FV461.
Is contract SPE2DR26FV461 an order under another contract?
Yes. SPE2DR26FV461 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV461 competed?
The extent of competition for SPE2DR26FV461 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award